Europe — EMA
Orlistato Ciclum
Orlistat, the active ingredient in Orlistato Ciclum, is a lipase inhibitor presented as a oral tablet for oral use. It treats obesity and helps weight management in adults with a body mass index of 30 kg/m2 or higher…
Request sourcing
What is Orlistat?
Orlistat, the active ingredient in Orlistato Ciclum, is a lipase inhibitor presented as a oral tablet for oral use. It treats obesity and helps weight management in adults with a body mass index of 30 kg/m2 or higher, or 27 kg/m2 with associated risk factors. GNH USA supplies Orlistato Ciclum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Orlistato Ciclum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Orlistat used for?
Orlistat acts on gastrointestinal fat absorption pathways and is indicated for obesity management.
- Obesity: Improves weight loss when used with a reduced‑calorie, low‑fat diet. - Overweight with risk factors: Assists in achieving modest weight reduction in patients with BMI 27–29.9 kg/m2 and cardiovascular risk factors. - Weight‑maintenance : Helps maintain weight loss after initial reduction by reducing dietary‑fat absorption.
What are the side effects of Orlistat?
Orlistat may but … … … … … … … … … … … … … ... ...
Common Side Effects: - S .... .... … ... … ... … ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... - … … .... .... ....… - ... ... … … ... .... - ... ... … … … .
Serious or Rare Side Effects: - … .... … \\ \\ . - … … … … - g t .
What precautions apply to Orlistat?
The ... g … t g … … \
